ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.255
      0.17%
      Bitcoin
      63,368.42
      1.11%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Incyte Corporation (INCY)

      7. Incyte Corporation (INCY) News

      INCY

      Incyte (INCY)

      Incyte Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INCY
      DateTimeSourceHeadlineSymbolCompany
      03/10/20226:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      03/01/20227:55AMGlobeNewswire Inc.Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic CancerNASDAQ:INCYIncyte Corporation
      02/22/20225:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      02/15/20228:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
      02/14/20224:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:INCYIncyte Corporation
      02/14/20222:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      02/14/20221:43PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INCYIncyte Corporation
      02/10/20228:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      02/08/20225:12PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:INCYIncyte Corporation
      02/08/20224:12PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:INCYIncyte Corporation
      02/08/20227:00AMBusiness WireIncyte Reports 2021 Fourth Quarter and Year-End Financial Results, and Provides 2022 Financial Guidance and Updates on Key Clinical ProgramsNASDAQ:INCYIncyte Corporation
      02/04/20229:18AMEdgar (US Regulatory)Schedule 13gNASDAQ:INCYIncyte Corporation
      02/03/20228:00AMBusiness WireIncyte to Present at Upcoming Investor ConferenceNASDAQ:INCYIncyte Corporation
      02/02/20224:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      02/01/20225:10PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INCYIncyte Corporation
      01/28/20229:01AMDow Jones NewsEli Lilly Reports Olumiant Setbacks in Lupus, Atopic DermatitisNASDAQ:INCYIncyte Corporation
      01/28/20228:00AMPR Newswire (US)Updates on OLUMIANT® (baricitinib) Phase 3 lupus program and FDA review for atopic dermatitisNASDAQ:INCYIncyte Corporation
      01/27/202212:15AMTipRanksAnalysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cortexyme (CRTX)NASDAQ:INCYIncyte Corporation
      01/26/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/26/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/25/20226:35PMTipRanksMizuho Securities Sticks to Its Hold Rating for Incyte (INCY)NASDAQ:INCYIncyte Corporation
      01/25/20225:43PMDow Jones NewsIncyte Says Withdrawing NDA for Parsaclisib Is a 'Business Decision'NASDAQ:INCYIncyte Corporation
      01/25/20224:30PMGlobeNewswire Inc.Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145NASDAQ:INCYIncyte Corporation
      01/25/20224:30PMBusiness WireIncyte Provides Update on Parsaclisib and MCLA-145NASDAQ:INCYIncyte Corporation
      01/21/20224:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/21/20224:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/21/20224:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/21/20224:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/21/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
      01/21/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INCYIncyte Corporation
       Showing the most relevant articles for your search:NASDAQ:INCY